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Abstract 
In order to confirm whether the binding sites for /l-calpain on the inner surface of erythrocyte membranes are substrate proteins 
themselves, we examined the binding properties of /L-calpain to p-calpain-pretreated inside-out membranes. When native p-calpain was 
incubated with CL-calpain-pretreated membranes, however, newly added calpain was degraded rapidly in a time- and Ca*+-dependent 
manner. Although the degradation of p-calpain was not inhibited by various proteinase inhibitors, it was strongly inhibited by digestible 
substrates for calpain that possess the ability to inhibit the binding of EL-calpain to erythrocyte membranes. On the other hand, when 
CL-calpain inactivated by N-el.hylmaleimide was incubated with CL-calpain-pretreated membranes, no degradation was observed. These 
results indicate that the degradation of CL-calpain occurs on the surface of CL-calpain-modified membranes and that it depends on the 
autoproteolytic activity of p-calpain itself. It seems likely that the autoproteolytic activity of p-calpain is accelerated markedly by some 
component(s) exposed on the surface of membranes during the pretreatment with CL-calpain. The possibility is thus proposed that cell 
membranes possess the ability to down-regulate calpain to protect cell membranes from overdegradation by excessively bound calpain. 
The active factor(s) in the membranes that can accelerate the autoproteolytic degradation of CL-calpain could be almost completely 
removed from CL-calpain-modified membranes by treatment with Triton X-100. 
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1. Introduction 
Calcium-activated neutral proteinase (calpain; EC 
3.4.22.17) is an intracellular cysteine proteinase distributed 
in various tissues and cells throughout the animal king- 
dom. Two forms of calpain have been identified, namely 
p-calpain which is activated at PM concentrations of 
calcium ions and m-calpain for which mM concentrations 
are required. An endogemms specific inhibitor, called cal- 
pastatin, also exists in various tissues and cells. Although 
the exact physiological function of these enzymes is not 
Abbreviations: kDa, kilodaltons; PAGE, polyacrylamide gel elec- 
trophoresis; TLCK, 1-chloro-3-tosylamido-7-amino-L-2-heptanone; E-64c, 
L-trans-epoxysuccinylleucylamitio(3-methyl)bu~ane; PMSF, phenyl- 
methanesulfonyl fluoride; DFP, diisopropyl fluorophosphate; IgG, im- 
munoglobulin G; NEM, N-ethylmaleimide. 
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yet established, the calpain/calpastatin system has been 
suggested to play important roles in cellular functions in 
response to mobilized calcium ions [l-5]. 
From many experiments in vitro, the mechanism under- 
lying the activation of calpain has been visualized. The 
activation process appears to include calpain autoproteoly- 
sis in the presence of calcium ions during which the 
N-terminal portion of the large subunit, which inhibits 
proteinase activity, is removed [6-81. This autoproteolysis 
reaction is accompanied by an increase in the calcium 
sensitivity of calpain. In the case of CL-calpain, the molecu- 
lar mass of the large subunit decreases from the original 79 
kDa to 76 kDa via a 77 kDa intermediate 171. Calpain 
binds to cytoplasmic membranes in a Ca*+-dependent 
manner and its autoproteolytic activation is facilitated 
greatly by this binding [9-111. We have also demonstrated 
that intracellular p-calpain in erythrocytes is activated 
upon increases in intracellular Ca*+ levels in the same 
manner as that established in vitro and that the cytoplasmic 
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cell membrane is also involved in the activation of CL- 
calpain in vivo as well as in vitro [12]. Although little is 
known about the precise binding sites for p-calpain on the 
membrane, our previous data strongly suggest that these 
are composed of substrate proteins rather than membrane 
phospholipids [11,17]. Therefore, we examined the binding 
of p-calpain to p-calpain-pretreated erythrocyte mem- 
branes to confirm that the binding sites are substrate 
proteins that can be removed by pretreatment. In the 
course of this experiment, however, we noticed that p- 
calpain newly added to p-calpain-pretreated membranes 
for binding assay is always degraded rapidly. We consid- 
ered that this phenomenon might be related to the down- 
regulation of calpain in which excess calpain molecules 
bound to membranes are to be removed. In this paper, we 
report in detail on the interaction between p-calpain and 
p-calpain-pretreated membranes, in order to clarify the 
mechanism for the degradation of p-calpain. 
2. Materials and methods 
2.1. Materials 
p-Calpain and calpastatin were purified from rabbit 
skeletal muscle and rabbit cardiac muscle, respectively, as 
described [13,14]. A monoclonal antibody specific for 
CL-calpain (lA,A,) that recognizes only the large subunit 
of p-calpain was produced by immunizing female 
BALB/c mice with purified CL-calpain from rabbit skeletal 
muscle and screening hybridoma cells that secreted CL- 
calpain specific antibodies, as described previously for the 
isolation of m-calpain specific antibodies [15]. Chemicals 
were purchased as follow: casein Hammersten from Merck; 
phosphatidylserine (PS), phosphatidylinositol (PI), phos- 
phatidylethanolamine (PE), phosphatidylcholine (PC), 
EGTA, TLCK, and human hemoglobin from Sigma; leu- 
peptin, E-64c and pepstatin A from Peptide Research 
Foundation; prestained molecular weight markers for im- 
munoblotting from Bio-Rad; nitrocellulose membranes 
from Schleicher and Schuell; peroxidase-conjugated anti- 
mouse IgG (Fab)’ from Medical and Biological Labs; 
Triton X-100 from Wako Chemicals. Other chemicals 
were obtained from Nacalai Tesque. 
2.2. Preparation of inside-out membrane uesicles 
Hemoglobin-free erythrocyte membranes (unsealed 
white ghosts) were prepared from fresh heparinized human 
peripheral blood and the inside-out vesicles were prepared 
from unsealed white ghosts according to the method of 
Steck and Kant [16]. The purity of inside-out vesicles was 
determined from the ratio of acetylcholinesterase activities 
in the presence and absence of 0.01% Triton X-100 and 
was estimated to be 85-90% [ll]. 
2.3. Preparation of p-calpain-treated erythrocyte mem- 
branes 
100 pg as protein of inside-out vesicles or unsealed 
white ghosts were incubated with 1 pg of purified CL- 
calpain at 25” C for 15 min in 20 mM Tris-HCl (pH 7.5) 
10 mM 2-mercaptoethanol in Ca2+-EGTA buffer contain- 
ing 1.4 PM free Ca 2+. The reaction was stopped by the 
addition of EGTA to a final concentration of 2 mM and 
the mixture was centrifuged at 35 000 X g for 10 min. The 
pelleted modified membranes were washed once with 20 
mM Tris-HCl (pH 7.5) containing 2 mM EGTA and three 
times with 20 mM Tris-HCl (pH 7.5) and resuspended in 
the same buffer to the original volume. 
2.4. Treatment of p-calpain-treated erythrocyte mem- 
branes with Triton X-100 
In order to remove the major integral proteins and 
glycerophospholipids, p-calpain-pretreated erythrocyte 
membranes were further treated with 0.5% (v/v) Triton 
X-100 as described before [17]. Triton X-loo-treated mem- 
branes were prepared from the p-calpain-pretreated white 
ghosts instead of the p-calpain-pretreated inside out vesi- 
cles, since Triton shells from CL-calpain-pretreated inside 
out vesicles were not recovered as pellets by centrifuga- 
tion, probably due to destruction of lining protein network. 
Triton shells were resuspended to the original volume. 
2.5. Detection of membrane-associated proteinase activity 
in p-calpain-treated membranes 
To detect proteinase activity at neutral pH, 41 pug of 
p-calpain-pretreated inside-out vesicles were incubated 
with 30 pg of alkali-denatured casein at 30” C for 180 min 
in 20 mM Tris-HCl, 250 PM CaCl,, 10 mM 2-mercapto- 
ethanol, pH 7.5. After incubation, the reaction mixture was 
cooled immediately on ice and centrifuged at 386000 X g 
for 10 min. The soluble fraction was heated in the sample 
buffer for SDS-PAGE at 100” C for 5 min. The proteinase 
activity was detected by electrophoresis on an SDS-poly- 
acrylamide gel. For the detection of acidic proteinase 
activity, 41 pg of I*.-calpain-pretreated inside-out vesicles 
were incubated with 30 pg of acid-denatured hemoglobin 
at 30” C for 180 min in 100 mM acetate, 250 mM CaCl,, 
10 mM 2-mercaptoethanol, pH 4.0. The other procedures 
were the same as for the assay of the neutral proteinase 
activity. 
2.6. Preparation of inactivated p-calpain 
Inactivated p-calpain was prepared by modification 
with N-ethylmaleimide according to the method described 
previously [18]. 
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2.7. Preparation of phospbrolipids from erythrocyte mem- 
branes 
The phospholipid fraction was prepared according to 
the method of Saito et al. 1193 and stored under N, at 
- 20” C. The amount of plnospholipid was determined by 
inorganic phosphorous anal.ysis [20]. 
2.8. Preparation of phospholipid vesicles 
Phospholipids or phospholipid mixtures isolated from 
erythrocyte membranes were dried on the bottom of assay 
tubes under a stream of nitrogen and sonicated in buffer 
prior to assay. 
2.9. Determination of free calcium ions 
Ca’+-EGTA buffer was prepared by mixing 1 mM 
EGTA and appropriate amounts of CaCl, solution in 20 
mM Tris-HCl (pH 7.51, 10 mM 2-mercaptoethanol. Free 
Cazf concentrations were calculated using a dissociation 
constant of 26.8 * 10m6 M [21]. 
2.10. Protein determination 
Protein concentration was determined by Lowry’s 
method [22] using bovine serum albumin as the standard 
protein. 
3. Results 
3.1. Degradation of p+alpain in the presence of I_L- 
calpain-pretreated erythrocyte membranes 
We have previously reported that the major binding site 
for p.-calpain on the inner surface of erythrocyte mem- 
branes are proteins rather than membrane phospholipids 
[11,17]. In the present study, we examined the binding of 
p-calpain to CL-calpain-pretreated membranes, in order to 
confirm that the binding site is a substrate protein for 
p-calpain itself. If the binding site is a substrate protein, 
the amount of CL-calpain binding to the membrane might 
be markedly decreased by pretreatment of membranes with 
p-calpain. 
However, when CL-calpain was newly added to the 
binding assay reaction mixture, it disappeared almost com- 
pletely not only from the membrane fraction, but also from 
the soluble fraction (Fig. 1). These results suggest the 
possibility that the newly added CL-calpain was degraded 
by exposure to p-calpain-modified membranes. The time 
course for the degradation of CL-calpain in the presence of 
p-calpain-modified membranes was explored in the pres- 
ence of 1.4 PM free calcium ions (Fig. 2). When p-calpain 
was incubated with intact membranes, the 79 kDa pro-en- 
zyme autoproteolyzed at once in a restricted manner, and 
ca2+- - + - + 
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Fig. 1. Binding properties of @alpain to intact and p-calpain-pretreated 
inside-out vesicles. 1 pg of native CL-calpain was incubated with 66 pg 
as protein of intact or p-calpain-pretreated inside-out vesicles at 2.5” C for 
2 min in 20 mM Tris-HCl (pH 7.51, 10 mM 2-mercaptoethanol containing 
1 mM EGTA or Ca*+-EGTA buffer (1.4 PM free Ca*+ ). The reaction 
was stopped by the addition of leupeptin to a final concentration of 1 mM 
and the mixture was immediately cooled on ice. The reaction mixture was 
ceurrifuged at 35000 X g for 10 min to separate the soluble fraction from 
the membrane fraction. The membrane fraction was washed three times, 
heated in the sample buffer for SDS-PAGE at 100” C for 5 min, and 
electrophoresed on SDS-polyacrylamide gels. The proteins in the soluble 
fraction were precipitated in 10% trichloroacetic acid and treated for 
electrophoresis as the membrane fraction. After electrophoresis, the pro- 
teins in the gels were transferred onto a nitrocellulose membrane and 
immunostained with monoclonal antibody (lA,A,) against the large 
subunit of EL-calpain. sup, soluble fraction; ppt, membrane fraction. 
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Fig. 2. Time-dependent degradation of CL-calpain in the presence of 
p-calpain-pretreated inside-out vesicles. 1 pg of native CL-calpain was 
incubated with 95 pg as protein of intact or I*.-calpain-pretreated inside-out 
vesicles at 25” C for various periods in 20 mM Tris-HCl (pH 7.5), 10 mM 
2-mercaptoethanol containing Ca*+-EGTA buffer (1.4 /.LM free Ca’+ 1. 
The reaction was stopped by the addition of the sample buffer for 
SDS-PAGE. The other procedures were the same as those in Fig. 1. The 
two faint bands indicated by arrows are the position of the degradation 
product of CL-calpain. 
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was converted to the 76 kDa active enzyme via a 77 kDa 
intermediate as previously reported [ll]. In the case of the 
p-calpain-modified membranes, however, p-calpain was 
degraded rapidly without restricted autoproteolysis. If p- 
calpain substrates are removed completely from mem- 
branes during the first incubation with p-calpain, it might 
induce rapid autoproteolysis of CL-calpain during the sec- 
ond incubation of p-calpain with the CL-calpain-treated 
membranes. As shown in Fig. 3, however, considerable 
amounts of I”-calpain substrates such as spectrin and band 
3 remained on the p-calpain-treated membranes. There- 
fore, it seems likely that the rapid degradation of p-calpain 
in the presence of p-calpain-treated membranes is induced 
not by exhaustion of substrate proteins. 
3.2. Effect of substrate proteins on the degradation of 
CL-calpain in the presence of p-calpain-pretreated mem- 
branes 
As a first step to analyze the degradation mechanism of 
CL-calpain, it is important to clarify whether the association 
of p-calpain with p-calpain-pretreated membranes is a 
prerequisite for degradation. Thus, we examined the effect 
of substrate proteins on the degradation of p-calpain since, 
as we previously reported, digestible substrate proteins for 
calpain, such as alkali-denatured casein and calpastatin 
- spectrin * 
42.7K * 
actin - 
- G-3-PD - 
31K * 
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1 2 3 4 
Fig. 3. Electrophoresis pattern of intact and CL-calpain-treated erythrocyte 
membrane proteins. The samples were electrophoresed on 12.5% SDS- 
polyacrylamide gels and the proteins were stained with Coomassie bril- 
liant blue. Lanes: 1, intact inside-out vesicles: 2, p-calpain-treated inside- 
out vesicles; 3, intact white ghosts; 4, I*-calpain-treated white ghosts. 
Spectrin, band 3, band 4.1, band 4.2, actin and glyceraldehyde-3-phos- 
phate dehydrogenase (G-3-PD) were identified by their mobilities. 
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Fig. 4. Effect of substrate proteins on the degradation of p-calpain by 
pCL-calpain-pretreated inside-out vesicles. 1 pg of native p-calpain (0.3 
unit) was incubated with 9.5 pg as protein of the CL-calpain-pretreated 
inside-out vesicles at 250 C for 2 min in 20 mM Tris-HCl (pH 7.5), 10 
mM 2-mercaptoethanol containing Ca2+-EGTA buffer (1.4 PM free 
Ca*+ ) in the presence of substrates. The other procedures were the same 
as those in Fig. 1. none, with Ca2+ only; calpastatin, with Ca2+ and 
rabbit cardiac muscle calpastatin (0.7 unit/4 pg/ml); hemoglobin, with 
Ca2+ and nondenatured hemoglobin (0.25 mg/ml); casein, with Ca2+ 
and alkali-denatured casein (0.25 mg/ml); BSA, with Ca2’ and nonde- 
natured bovine serum albumin (0.25 mg/ml). sup, soluble fraction; ppt, 
membrane fraction. 
(suicide substrate), can inhibit the binding of CL-calpain to 
erythrocyte membranes [ll]. The characteristics of these 
substrate proteins could prove very useful answering this 
question. As undigestible proteins, nondenatured 
hemoglobin and BSA were chosen. As shown in Fig. 4, the 
degradation of p-calpain in the presence of p-calpain- 
modified membranes was strongly interrupted by di- 
gestible substrates. On the other hand, undigestible sub- 
strates had little or no effect on the degradation of p- 
calpain. These results strongly suggest that the degradation 
of p-calpain is triggered by the association of p-calpain 
with p-calpain-modified membranes. 
3.3. Effect of proteinase inhibitors on the degradation of 
v-calpain in the presence of p-calpain-pretreated mem- 
branes 
There are a few possible reasons for the degradation of 
CL-calpain by p-calpain-pretreated membranes. One is that 
some unidentified membrane-associated proteinase is ex- 
posed and/or activated by pretreatment with p-calpain, 
and the newly added p-calpain is a good substrate for this 
proteinase. In order to explore this possibility, we exam- 
ined the effects of various proteinase inhibitors on the 
degradation of p-calpain. As shown in Fig. 5, however, a 
proteinase inhibitor cocktail containing leupeptin, E-64c, 
TICK, and pepstatin A did not inhibit the degradation of 
p-calpain on CL-calpain-pretreated membranes. PMSF and 
DFP also showed no inhibitory effect (data not shown). In 
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Fig. 5. Effect of proteinase inhibitors on the degradation of p-calpain on FL-calpain-pretreated inside-out vesicles. 1 /Lg of native CL-calpain was incubated 
with 53 pg as protein of intact or CL-calpain-pretreated inside-out vesicles at 25” C for 2 min in 20 mM Tris-HCl (pH 7.5), 10 mM 2-mercaptoethanol 
containing 1 mM EGTA or Ca*---EGTA buffer (1.4 PM free Ca2+ ) in the presence or absence of proteinase inhibitor cocktail (500 /IM leupeptin, 500 
PM E-64c, 500 PM TLCK and 50 WM pepstatin A). The other procedures were the same as those in Fig. 1. sup, soluble fraction; ppt, membrane fraction. 
separate experiments, we could detect proteinase activities 
in p-calpain-pretreated membranes at neutral and acidic 
pH, using alkali-denatured casein and acid-denatured 
hemoglobin as substrates, respectively. Both proteinase 
activities, however, were completely inhibited in the pres- 
ence of the same inhibitor cocktail (data not shown). 
Therefore, the possibility that some membrane-associated 
proteinase is involved in the degradation of p-calpain can 
be excluded. 
3.4. Degradation of native and NEM-inactivated p- 
calpains on p-calpain-pretreated membranes 
It has been shown that calpain is highly susceptible to 
Ca’+-induced autoproteolysis and that restricted autoprote- 
olysis plays an essential regulatory role in activation as a 
ca2+ - - + 
113K w 
82K * ,78K 
*-. -U-c e- ‘T 76K 
49.5K - 
I-l I I 
native-p-caipain NE&pcalpain 
Fig. 6. Degradation of native and NEM-inactivated CL-calpains on p- 
calpain-pretreated inside-out vesicles. 1 pg of native or NEM-inactivated 
p-calpain was incubated with 96 pg as protein of /L-calpain-pretreated 
inside-out vesicles at 25” C for 15 min in 20 mM Tris-HCl (pH 7.51, 10 
mM 2-mercaptoethanol containing 1 mM EGTA or Ca’+-EGTA buffer 
(1.4 PM free Ca*+ ). The reaction was stopped by the addition of the 
sample buffer for SDS-PAGE. The other procedures were the same as 
those in Fig. 1. 
proteinase. However, extensive autoproteolysis can lead to 
the loss of activity and ultimate destruction of the enzyme. 
Therefore, it is likely that the degradation of p-calpain 
proceeds autoproteolytically on p-calpain-modified mem- 
branes if some component(s) with an ability to accelerate 
the autoproteolytic activity of CL-calpain is exposed on 
membrane surfaces upon treatment with p-calpain. To 
verify whether the degradation of CL-calpain depends on 
the autoproteolytic activity of p-calpain itself, N-ethyl- 
maleimide-inactivated CL-calpain was incubated with p- 
calpain-pretreated membranes (Fig. 6). When this inacti- 
vated p-calpain was incubated with active form of p- 
calpain (76 kDa1, it was degraded and the degradation 
pattern was the same as in the autoproteolysis of native 
p-calpain [ 181, suggesting no gross conformational change 
in p-calpain molecule by the treatment with N-ethylmalei- 
mide. Intact EL-calpain was degraded in a Ca’+-dependent 
manner as described above. On the other hand, no degrada- 
tion of inactivated p-calpain was observed. These results 
clearly demonstrate that the degradation of p-calpain on 
p-calpain-modified membranes occurs autoproteolytically. 
However, one question now arises. Why could not the 
proteinase inhibitor cocktail, which contains leupeptin and 
E-64c, inhibit the autoproteolytic degradation of CL-calpain? 
Although we have no good explanation for this at the 
moment, it is possible that the velocity of the autoprote- 
olytic degradation of p-calpain is much faster than that of 
the association of CL-calpain with proteinase inhibitors, or, 
because the autoproteolytic degradation proceeds in- 
tramolecularly, substrate-like inhibitors can not interact 
with the active sites of p-calpain. 
3.5. Effect of Triton shells prepared from p-calpain-pre- 
treated erythrocyte membranes on the autodegradation of 
jkcalpain 
In order to characterize the factor(s) that exists on the 
surface of p-calpain-modified membranes and induce the 
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Fig. 7. Effect of Triton shells prepared from CL-calpain-pretreated white 
ghosts on the autodegradation of CL-calpain. 1 kg of native p-calpain was 
incubated with intact white ghosts, p-calpain-pretreated white ghosts or 
Triton shells prepared from the CL-calpain-pretreated white ghosts (95 pg, 
75 pg, 50 pg as protein, respectively) at 25” C for 5 min in 20 mM 
Tris-HCl (pH 7.51, 10 mM 2-mercaptoethanol containing Ca”-EGTA 
buffer (1.4 PM free Ca*+ ). The reaction was stopped by the addition of 
the sample buffer for SDS-PAGE. The other procedures were the same as 
those in Fig. 1. 
autoproteolytic degradation of p-calpain, we examined the 
effect of Triton shells prepared from p-calpain-modified 
membranes on the autoproteolytic degradation of p- 
calpain. In this experiment, we used unsealed white ghosts 
instead of inside-out vesicles as a starting material to 
prepare Triton shells, since it is very difficult to prepare 
97.4K 
66.2K 
42.7K 
21.5K t 
0 Om6 1.4 6.1 20 
PE 
I: 
0.6 1.4 6.1 20 
Triton shells from p-calpain-pretreated inside-out vesicles. 
No appreciable difference was found between the CL- 
calpain-treated inside-out vesicles and white ghosts in the 
composition of remaining membrane proteins (Fig. 3). 
p-Calpain, when incubated with intact unsealed white 
ghosts, was activated autoproteolytically in a restricted 
manner, while in the case of the p-calpain-modified white 
ghosts, it was degraded (Fig. 7). These results are identical 
to those of intact and the p-calpain-modified inside-out 
vesicles. On the other hand, when p-calpain was incubated 
with Triton shells, no degradation was observed and the 
enzyme was autoproteolytically activated in a restricted 
manner as occurs when intact unsealed white ghosts were 
used. This result clearly shows that the factor(s) that 
induces the autoproteolytic degradation of p-calpain was 
removed from p-calpain-modified membranes by treat- 
ment with Triton X-100. 
3.6. Effect of phospholipids on the autoproteolysis of p- 
calpain 
We showed previously that most integral proteins and 
glycerophospholipids are extracted from erythrocyte white 
ghosts by treatment with Triton X-100 1171. In this paper, 
we thus examined the effect of glycerophospholipids on 
the autoproteolysis of EL-calpain (Fig. 8). In the case of 
phosphatidylethanolamine, the 79 kDa subunit of p-calpain 
was autoproteolyzed to an active 76 kDa form and consid- 
erable amounts of active species accumulated. On the other 
hand, p-calpain was degraded in the presence of phospha- 
Free Ca2+ Concentration (MM) 
MPLS 
0.6 IA 6.1 20 
79K 
76K 
Fig. 8. Effect of phospholipids on the autoproteolysis of CL-calpain. 5 pg of native CL-calpain was incubated at 250 C for 2 min in 20 mM Tris-HCI (pH 
7.5), 10 mM 2-mercaptoethanol containing Ca ‘+-EGTA buffer with various concentrations of free Ca2+ . m the presence or absence of phospholipids. The 
reaction was stopped by the addition of the sample buffer for SDS-PAGE. The samples were electrophoresed on 12.5% SDS-polyacrylamide gels and the 
proteins were stained with Coomassie brilliant blue. none, with Ca2+ only; PE, with Ca*+ and phosphatidylethanolamine (100 pg/ml); PI, with Ca2+ and 
phosphatidylinositol (100 pg/ml); MPLs, with Ca*+ and a phospholipid mixture (100 pg/ml) from erythrocyte white ghosts. 
M. Inomata, S. Kawashima/Biochimica et Biophysics Acta 1235 (1995) 107-114 113 
tidylinositol even at low concentrations of calcium ions, 
and no significant accumulation of an active species was 
observed. The autoproteolytic behavior of p-calpain in the 
presence of phosphatidylinositol is very similar to that 
observed with p-calpain-modified membranes. The phos- 
pholipid mixture isolated from erythrocyte white ghosts 
showed the same effect as phosphatidylethanolamine rather 
than phosphatidylinositol. Although phosphatidylserine and 
phosphatidylcholine were also potent stimulators of the 
autoproteolytic activation of p-calpain, it was much weaker 
than that of phosphatidyle:thanolamine (data not shown). 
4. Discussion 
It is desirable to use @calpain and membrane from the 
same source to analyze the mode of binding and subse- 
quent event on the membranes. But membrane prepara- 
tions, especially inside-out vesicles, from rabbit erythro- 
cytes were not satisfactory in purity and could not be used 
in our experiments. Previously, we compared the action of 
rabbit p-calpain on unsealed white ghosts from human and 
rabbit erythrocytes and obtained similar results for the 
effects of substrate proteins and calpastatin except for 
some differences in the arnount of CL-calpain bound Ca*+- 
dependently to the membranes [ll]. Furthermore, we ob- 
served that same membrane proteins on both membranes 
such as spectrin, band 3 and band 4.1 are degraded by 
rabbit p-calpain (data not shown). We therefore concluded 
that the results obtained in the present experiments using a 
heterologous combination of p-calpain and membranes 
reflects those obtained using homologous systems. 
Most animal cells ancl tissues contain two species of 
calpain and its specific inhibitor protein, calpastatin. There 
have also been a few reports that activator proteins for 
calpain can be found in s.everal tissues and cells [23-261. 
Thus, it is considered that calpain activity is regulated by 
calcium ions and those endogenous regulatory proteins. 
However, the precise regulatory mechanism of calpain 
activity in living cells is only poorly understood. 
In this report, we describe an interesting phenomenon 
that seems to be related lo a novel regulatory mechanism 
of calpain activity by cell membranes. Namely, we have 
verified that erythrocyte membranes obtain the ability to 
accelerate the degradation of CL-calpain by pretreatment 
with p-calpain. Although, the degradation of p-calpain in 
the presence of p-calpain-modified membranes was not 
inhibited by various prot’einase inhibitors, it was strongly 
inhibited by the addition of digestible substrates that pos- 
sess the ability to prevent the binding of calpain to mem- 
branes (Figs. 4 and 5). When CL-calpain inactivated with 
N-ethylmaleimide was incubated with p-calpain-modified 
membranes, no degradation was observed (Fig. 6). These 
results strongly suggest that the degradation of p-calpain 
proceeds on the surface of the p-calpain-modified mem- 
branes and it depends on the autoproteolytic activity of 
CL-calpain itself. We could not detect significant amounts 
of typical autoproteolytic fragments of p-calpain during 
the incubation of CL-calpain with the CL-calpain-modified 
membranes. But it was verified that k-calpain was de- 
graded autoproteolytically without significant accumula- 
tion of the typical fragments in the presence of phospha- 
tidylinositol (Fig. 8). It seems quite probable that this type 
of ‘unusual’ degradation of CL-calpain occurs as a result of 
extensive acceleration of its autoproteolytic activity by 
some component that becomes exposed on the surface of 
membranes by treatment with p-calpain. On the basis of 
the existing data, we believe that the above phenomenon 
functions as a mechanism for the down-regulation for 
calpain, in which calpain molecules excessively bound 
and/or having already functioned on membranes are re- 
moved. 
It is thought that calpain usually exists as an inactive 
proenzyme in the cytosolic part of living cells and binds to 
membranes in response to mobilized calcium ions. Then, it 
autoproteolyzes immediately to an active form on mem- 
branes, and hydrolyzes various substrate proteins such as 
cytoskeletal proteins and membrane proteins. Therefore, if 
the cell membranes were attacked continuously by calpain 
without restriction, it would cause great damage to cellular 
function. Accordingly, it is conceivable that cell mem- 
branes are provided with a function to protect themselves 
from excessive attack by calpain. In many cells, however, 
calpastatin is present in concentrations sufficient to com- 
pletely block all calpain activity. Thus, further investiga- 
tion is required to clarify whether this down-regulation 
system actually functions in living cells. It has also been 
reported that calpastatin can not interact with membrane- 
associated calpain [27]. 
The activity that acts to accelerate the autoproteolytic 
degradation of CL-calpain was mostly removed from p- 
calpain-modified membranes by treatment with Triton X- 
100 (Fig. 7) together with most integral membrane proteins 
and glycerophospholipids. Thus, we first examined the 
effect of various glycerophospholipids on the autoproteoly- 
sis of CL-calpain under membrane-free conditions. It is 
generally accepted that phosphatidylinositol can reduce the 
Ca2+ concentration needed .for autoproteolytic activation 
of calpain. Under our experimental conditions, however, 
the factor(s) that accelerates the autoproteolytic degrada- 
tion of p-calpain in p-calpain-modified membranes was 
mimicked by phosphatidylinositol (Fig. 8). It was demon- 
strated by Cong et al. [28] that phosphatidylinositol 
markedly reduces the specific activity of autoproteolyzed 
p-calpain (active form) without changing the Ca2+-sensi- 
tivity. This phenomenon might be regarded as the down- 
regulation of an active form of CL-calpain by phosphatidyl- 
inositol. Phosphatidylinositol might act to accelerate the 
degradation velocity of the active form leading to inactiva- 
tion. But, pretreatment of p-calpain-modified membranes 
with phospholipase C also has no effect on the autoprote- 
olytic degradation of p-calpain (data not shown). Conse- 
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quently, it seems unlikely that phosphatidylinositol alone 
causes the autoproteolytic degradation of p-calpain. Thus, 
it is interesting and of significance to examine the compo- 
nents that are extracted from membranes by treatment with 
Triton X-100. Such work is currently underway in our 
laboratory. 
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